Showing 1,462 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

How Secrecy in Medical Research Harms our Health

Editor's pick
Open Society Foundations
5 July 2012
Pharmaceutical industry

EU Parliament Rejects ACTA; Allowing for Continued Access to Generic Medicines in Developing Countries

Editor's pick
MSF
4 July 2012
Clinical trials

How to Tell When A Drug Company Fibs About Clinical Trial Results

Editor's pick
The Street
4 July 2012
Pharmaceutical industry

Tanzania: Muhas Develops Anti-Retroviral Formula

Editor's pick
AllAfrica
3 July 2012
Access to healthcare

Activists in the EECA demand a tenfold reduction of the price for pegylated interferons

Editor's pick
EATG
2 July 2012
Pharmaceutical industry

HIV generics take over the antivirals market

Editor's pick
GBI Research
2 July 2012
Global health initiatives

Gates Foundation readies a round of tempting biotech investments

Editor's pick
Fierce Biotech
2 July 2012
New & experimental hepatitis C treatment

Medivir announces an interferon-free phase II combination trial of hepatitis C drugs TMC435 and daclatasvir to commence shortly

Editor's pick
Medivir
29 June 2012
New & experimental HIV treatments

Gilead Sciences files for approval of cobicistat

Editor's pick
Bloomberg BusinessWeek
29 June 2012
Access to healthcare

MEPs to 'finish off' ACTA on 4 July

Editor's pick
EurActiv
22 June 2012
Access to healthcare

If you can’t join ‘em, beat ‘em: new industry effort a jab at patent pool?

Editor's pick
Intellectual Property Watch
22 June 2012
Pharmaceutical industry

Roche did not report US patients’ deaths

Editor's pick
Financial Times
22 June 2012
New & experimental hepatitis C treatment

Idenix hep C drug shows promise in mid-stage study

Editor's pick
Reuters
20 June 2012
New & experimental HIV treatments

European Medicines Agency Validates Gilead ’s Marketing Application for Elvitegravir for Treatment of HIV Infection

Editor's pick
Gilead press release
19 June 2012
Pharmaceutical industry

AHF: Gilead Pulls AIDS Funding After AHF Advocacy Efforts

Editor's pick
Market Watch (press release)
15 June 2012
PrEP

FDA delays decision on drug to prevent HIV

Editor's pick
Washington Post
9 June 2012
Access to healthcare

China changes patent law in fight for cheaper drugs

Editor's pick
Reuters
9 June 2012
PrEP

FDA Moves Deadline for Approval of Truvada as PrEP to September

Editor's pick
Mapping Pathways
8 June 2012
Access to healthcare

South Africa: Addressing Tenofovir Shortages

Editor's pick
AllAfrica
8 June 2012
Pharmaceutical industry

The business of HIV: a huge, strange drug market

Editor's pick
The Economist
1 June 2012
Pharmaceutical industry

Vertex Goes From Bad Data To A Bad Promotion

Editor's pick
Pharmalot
1 June 2012
Access to healthcare

South Africa: Tenofovir Shortages Continue

Editor's pick
AllAfrica
31 May 2012
Hepatitis C treatment

FDA says Vertex promotional material overstates benefits of hepatitis C drug

Editor's pick
Boston Globe
31 May 2012
New & experimental hepatitis C treatment

GSK seeks to expand low-platelet drug Promacta to hepatitis C patients

Editor's pick
MedCity News
31 May 2012